These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
72 related articles for article (PubMed ID: 8476435)
21. Dystrophinopathy carrier determination and detection of protein deficiencies in muscular dystrophy using lentiviral MyoD-forced myogenesis. Cooper ST; Kizana E; Yates JD; Lo HP; Yang N; Wu ZH; Alexander IE; North KN Neuromuscul Disord; 2007 Apr; 17(4):276-84. PubMed ID: 17303423 [TBL] [Abstract][Full Text] [Related]
22. Dystrophin expression in the human retina is required for normal function as defined by electroretinography. Pillers DA; Bulman DE; Weleber RG; Sigesmund DA; Musarella MA; Powell BR; Murphey WH; Westall C; Panton C; Becker LE Nat Genet; 1993 May; 4(1):82-6. PubMed ID: 8513332 [TBL] [Abstract][Full Text] [Related]
23. An exon skipping-associated nonsense mutation in the dystrophin gene uncovers a complex interplay between multiple antagonistic splicing elements. Disset A; Bourgeois CF; Benmalek N; Claustres M; Stevenin J; Tuffery-Giraud S Hum Mol Genet; 2006 Mar; 15(6):999-1013. PubMed ID: 16461336 [TBL] [Abstract][Full Text] [Related]
24. Intraperitoneal administration of phosphorothioate antisense oligodeoxynucleotide against splicing enhancer sequence induced exon skipping in dystrophin mRNA expressed in mdx skeletal muscle. Takeshima Y; Yagi M; Wada H; Matsuo M Brain Dev; 2005 Oct; 27(7):488-93. PubMed ID: 16198206 [TBL] [Abstract][Full Text] [Related]
26. An alternative dystrophin transcript specific to peripheral nerve. Byers TJ; Lidov HG; Kunkel LM Nat Genet; 1993 May; 4(1):77-81. PubMed ID: 8513330 [TBL] [Abstract][Full Text] [Related]
27. Phenotypic improvement of dystrophic muscles by rAAV/microdystrophin vectors is augmented by Igf1 codelivery. Abmayr S; Gregorevic P; Allen JM; Chamberlain JS Mol Ther; 2005 Sep; 12(3):441-50. PubMed ID: 16099410 [TBL] [Abstract][Full Text] [Related]
28. Expression of human dystrophin following the transplantation of genetically modified mdx myoblasts. Moisset PA; Gagnon Y; Karpati G; Tremblay JP Gene Ther; 1998 Oct; 5(10):1340-6. PubMed ID: 9930339 [TBL] [Abstract][Full Text] [Related]
29. Expression of Dp71 in Müller glial cells: a comparison with utrophin- and dystrophin-associated proteins. Claudepierre T; Mornet D; Pannicke T; Forster V; Dalloz C; Bolaños F; Sahel J; Reichenbach A; Rendon A Invest Ophthalmol Vis Sci; 2000 Jan; 41(1):294-304. PubMed ID: 10634634 [TBL] [Abstract][Full Text] [Related]
30. Induced dystrophin exon skipping in human muscle explants. McClorey G; Fall AM; Moulton HM; Iversen PL; Rasko JE; Ryan M; Fletcher S; Wilton SD Neuromuscul Disord; 2006 Oct; 16(9-10):583-90. PubMed ID: 16919955 [TBL] [Abstract][Full Text] [Related]
31. In vivo targeted repair of a point mutation in the canine dystrophin gene by a chimeric RNA/DNA oligonucleotide. Bartlett RJ; Stockinger S; Denis MM; Bartlett WT; Inverardi L; Le TT; thi Man N; Morris GE; Bogan DJ; Metcalf-Bogan J; Kornegay JN Nat Biotechnol; 2000 Jun; 18(6):615-22. PubMed ID: 10835598 [TBL] [Abstract][Full Text] [Related]
32. Newly recognized exons induced by a splicing abnormality from an intronic mutation of the dystrophin gene resulting in Duchenne muscular dystrophy. Mutations in brief no. 213. Online. Ikezawa M; Nishino I; Goto Y; Miike T; Nonaka I Hum Mutat; 1999; 13(2):170. PubMed ID: 10094556 [TBL] [Abstract][Full Text] [Related]
33. DMD pseudoexon mutations: splicing efficiency, phenotype, and potential therapy. Gurvich OL; Tuohy TM; Howard MT; Finkel RS; Medne L; Anderson CB; Weiss RB; Wilton SD; Flanigan KM Ann Neurol; 2008 Jan; 63(1):81-9. PubMed ID: 18059005 [TBL] [Abstract][Full Text] [Related]
34. In vitro splicing analysis showed that availability of a cryptic splice site is not a determinant for alternative splicing patterns caused by +1G-->A mutations in introns of the dystrophin gene. Habara Y; Takeshima Y; Awano H; Okizuka Y; Zhang Z; Saiki K; Yagi M; Matsuo M J Med Genet; 2009 Aug; 46(8):542-7. PubMed ID: 19001018 [TBL] [Abstract][Full Text] [Related]
35. [Detection of extensive deletions and duplications in the dystrophin gene]. Fajkusová L; Kuhrová V; Hájek J; Fajkus J Cas Lek Cesk; 1997 Mar; 136(5):148-50. PubMed ID: 9221188 [TBL] [Abstract][Full Text] [Related]
36. Expression of full-length human dystrophin cDNA in mdx mouse muscle by HVJ-liposome injection. Yanagihara I; Inui K; Dickson G; Turner G; Piper T; Kaneda Y; Okada S Gene Ther; 1996 Jun; 3(6):549-53. PubMed ID: 8789805 [TBL] [Abstract][Full Text] [Related]
37. Characterization of a complex Duchenne muscular dystrophy-causing dystrophin gene inversion and restoration of the reading frame by induced exon skipping. Madden HR; Fletcher S; Davis MR; Wilton SD Hum Mutat; 2009 Jan; 30(1):22-8. PubMed ID: 18570328 [TBL] [Abstract][Full Text] [Related]
38. Human and murine dystrophin mRNA transcripts are differentially expressed during skeletal muscle, heart, and brain development. Bies RD; Phelps SF; Cortez MD; Roberts R; Caskey CT; Chamberlain JS Nucleic Acids Res; 1992 Apr; 20(7):1725-31. PubMed ID: 1579466 [TBL] [Abstract][Full Text] [Related]
39. Expression of four alternative dystrophin transcripts in brain regions regulated by different promoters. Górecki DC; Monaco AP; Derry JM; Walker AP; Barnard EA; Barnard PJ Hum Mol Genet; 1992 Oct; 1(7):505-10. PubMed ID: 1307251 [TBL] [Abstract][Full Text] [Related]
40. Direct detection of dystrophin gene rearrangements by analysis of dystrophin mRNA in peripheral blood lymphocytes. Roberts RG; Barby TF; Manners E; Bobrow M; Bentley DR Am J Hum Genet; 1991 Aug; 49(2):298-310. PubMed ID: 1867192 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]